AVP and endometrial cancer: As ADH lesions already exhibit significant genetic changes (aneuploidy, loss of heterozygosity, gross chromosomal rearrangement and methylation changes) it is expected that the immune system will already be activated and in hyperplastic endometrial cancer this has been shown.